IRIS
OLIVIERI, Attilio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.503
EU - Europa 9.794
AS - Asia 9.233
SA - Sud America 2.738
Continente sconosciuto - Info sul continente non disponibili 627
AF - Africa 536
OC - Oceania 11
AN - Antartide 1
Totale 40.443
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.144
SG - Singapore 2.653
BR - Brasile 2.119
VN - Vietnam 2.113
RU - Federazione Russa 1.689
UA - Ucraina 1.496
IT - Italia 1.412
CN - Cina 1.331
IE - Irlanda 951
HK - Hong Kong 912
DE - Germania 890
SE - Svezia 833
TR - Turchia 760
FI - Finlandia 605
DK - Danimarca 599
FR - Francia 575
KR - Corea 324
GB - Regno Unito 323
IN - India 239
AR - Argentina 229
BD - Bangladesh 224
CI - Costa d'Avorio 180
CA - Canada 171
MA - Marocco 125
MX - Messico 118
NL - Olanda 109
ID - Indonesia 101
EC - Ecuador 91
JP - Giappone 88
IQ - Iraq 86
ZA - Sudafrica 86
CO - Colombia 82
VE - Venezuela 66
PL - Polonia 62
UZ - Uzbekistan 56
ES - Italia 54
EU - Europa 54
CL - Cile 45
PY - Paraguay 45
PK - Pakistan 42
AT - Austria 41
TN - Tunisia 40
PH - Filippine 36
EG - Egitto 29
PE - Perù 28
MY - Malesia 27
SA - Arabia Saudita 27
BE - Belgio 25
DZ - Algeria 25
KZ - Kazakistan 25
AE - Emirati Arabi Uniti 24
JO - Giordania 24
UY - Uruguay 19
CZ - Repubblica Ceca 16
LT - Lituania 16
TH - Thailandia 15
IL - Israele 14
CR - Costa Rica 13
KE - Kenya 13
OM - Oman 13
BO - Bolivia 12
NP - Nepal 12
RS - Serbia 12
AZ - Azerbaigian 11
RO - Romania 11
AL - Albania 10
TW - Taiwan 10
LB - Libano 9
AU - Australia 8
CH - Svizzera 8
DO - Repubblica Dominicana 8
ET - Etiopia 8
GR - Grecia 8
HU - Ungheria 8
KG - Kirghizistan 8
PS - Palestinian Territory 8
SN - Senegal 8
BG - Bulgaria 7
GT - Guatemala 7
JM - Giamaica 7
KW - Kuwait 7
PA - Panama 7
HN - Honduras 6
IR - Iran 6
MN - Mongolia 6
PR - Porto Rico 6
AO - Angola 5
SY - Repubblica araba siriana 5
GA - Gabon 4
HR - Croazia 4
MD - Moldavia 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BN - Brunei Darussalam 3
BZ - Belize 3
GE - Georgia 3
LU - Lussemburgo 3
LV - Lettonia 3
MK - Macedonia 3
NO - Norvegia 3
Totale 39.819
Salva come PNG Salva come JPEG
Città #
Ashburn 2.467
Jacksonville 1.574
Singapore 1.449
Dallas 1.032
Chandler 1.023
Fairfield 945
Dublin 944
Hong Kong 884
Boardman 851
Ho Chi Minh City 709
San Jose 613
Wilmington 525
Hanoi 473
The Dalles 463
Houston 413
New York 403
Council Bluffs 376
Princeton 364
Woodbridge 364
Lawrence 358
Seattle 357
Lauterbourg 345
Des Moines 325
San Mateo 321
Los Angeles 304
Moscow 303
Beijing 276
Cambridge 257
Milan 257
Ann Arbor 252
Helsinki 245
Hefei 229
São Paulo 184
Abidjan 180
Chicago 155
San Diego 139
Munich 126
Da Nang 122
Buffalo 105
Centro 104
Orem 100
Haiphong 90
Turin 75
Ancona 73
Santa Clara 73
London 72
Redmond 70
Miano 68
Shanghai 64
Guangzhou 61
Rio de Janeiro 58
Tokyo 58
Denver 54
Rome 54
Salt Lake City 54
Turku 53
Curitiba 51
Chennai 48
Warsaw 47
Amsterdam 46
Tashkent 44
Hải Dương 42
Johannesburg 42
Pune 42
Toronto 42
Brooklyn 41
Montreal 41
Belo Horizonte 40
Phoenix 39
Atlanta 38
Frankfurt am Main 38
Washington 38
Nuremberg 37
Stockholm 37
Biên Hòa 36
Thái Bình 36
Boston 35
Brasília 34
Columbus 34
San Francisco 34
Guayaquil 31
Venice 31
Philadelphia 30
Elk Grove Village 29
Manchester 29
Wuhan 29
Campinas 28
Izmir 27
Pianella 27
Poplar 27
Porto 27
Baghdad 25
Mumbai 25
Quito 25
Dhaka 24
Marche 24
Medellín 24
Mexico City 24
Thái Nguyên 24
Fortaleza 21
Totale 23.386
Salva come PNG Salva come JPEG
Nome #
The Time Has Come for Targeted Therapies for AML: Lights and Shadows 382
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease 329
Specific Anti-Nuclear Antibodies, Clinical Features and Outcome Following Treatment with Nilotinib In Patients with Chronic Graft-Versus-Host Disease. The 44th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Poster Sessions 314
A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation. 224
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 211
Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome? 204
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 197
Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study 192
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 189
Predicting failure of hematopoietic stem cell mobilization before it starts: The predicted poor mobilizer (pPM) score 182
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease 181
A new method to assess the viability of collected CD34+ cells before reinfusion: a prospective study in 50 autotransplanted patients. 180
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 175
A predictive model of varicella-Zoster virus infection after autologous peripheral blood progenitor cell transplantation 171
A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study. 171
Glial-like differentiation potential of human mature adipocytes 170
Nilotinib Treatment of Patients Affected by Chronic Graft-versus-Host Disease Reduces Collagen Production and Skin Fibrosis by Downmodulating the TGF-β and p-SMAD Pathway 167
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 167
'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 166
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 164
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 164
Application of infrared thermography to determine the correlation between skin temperature and onset of graft versus host disease in patients after bone marrow transplantation: A preliminary study 163
BEEAM (BENDAMUSTINE, ETOPOSIDE, ARA-C, MELPHALAN) PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANT IS SAFE AND EFFECTIVE IN AGGRESSIVE B-CELL NON HODGKIN LYMPHOMA: A PHASE II MULTICENTER STUDY 162
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 160
Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis 159
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 159
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib 158
Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report 156
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 155
[Hodgkin's lymphoma and secondary leukemias]. 154
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 153
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation. 153
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: A nationwide retrospective survey from Italy 152
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 151
[Differentiating agents in myelodysplastic syndromes. Analysis of personal cases]. 151
Bone marrow adipocytes support haematopoietic stem cell survival 151
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma. 151
[Autoimmune thrombocytopenic purpura and circulating immune complexes]. 150
The exosomal surface phenotype and inflamma-miR cargo correlate with MDS diagnosis 149
Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective study 148
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: A GITMO survey on 809 patients autografted in first complete remission 147
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. 146
Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: A survey from the ALWP of the EBMT 145
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy 144
Direct demonstration of cytokeratin filaments by electron microscopy in K562 cell lines in liquid culture 144
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma 144
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients. 143
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 143
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study 142
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 142
[Evaluation of the colonization efficiency and in vitro drug sensitivity of the continuous K 562 line]. 141
[Polyneuropathies associated with lymphoplasmacytic dyscrasias: the clinical and instrumental characteristics of a 38-patient case load]. 141
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 140
Hematologic reconstitution after PBPC autotransplantation:comparison between programmed-rate freezing and uncontrolled freezing at –80° 139
Modern management of anthracycline-induced cardiotoxicity in lymphoma patients: Low occurrence of cardiotoxicity with comprehensive assessment and tailored substitution by nonpegylated liposomal doxorubicin 139
Plasticity of human dedifferentiated adipocytes toward endothelial cells 138
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 138
LATE EFFECTS IN Hodgkin's POPULATION Treated BETWEEN 1980-2005 IN A SINGLE INSTITUTION 138
Real‐world assessment of treatment patterns and outcomes in patients with relapsed‐refractory multiple myeloma in an Italian haematological tertiary care centre 137
A rare case of aCML associated with CNS involvement and with aggressive clinical course 137
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation 136
POOR RESPONSE TO FIRST BNT162B2 SARS-COV-2 VACCINE DOSE IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT 136
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA. 135
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 134
Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM) 133
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 133
Neurologic Complications IIN 169 Consecutive Allogeneic Stem Cell Transplants: Etiology, Clinical Syndromes and Outcome 132
Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications 131
[Polychemotherapy versus melphalan-prednisone in multiple myeloma]. 130
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 130
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation 130
Conditioning Regimens for Frail Patients with Acute Leukemia Undergoing Allogeneic Stem Cell Transplant: How to Strike Gently 130
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell trasplantation 129
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 128
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 128
Hematologic reconstitution after PBPC autotransplantation: comparison between programmed-rate freezing and uncontrolled-rate freezing at -80 degrees C 127
Current Main Topics in Multiple Myeloma 126
[Beta 2-microglobulin in lymphoproliferative disorders]. 126
Molecular and functional characterization of human bone marrow adipocytes 126
A novel homozygous stop-codon mutation in human HFE responsible for nonsense-mediated mRNA decay 125
A multicentre, double-blind, randomised trial comparing ondansetron versus ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis 125
[Hairy cell leukemia: therapy with lithium carbonate]. 125
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 125
History and scientific production of clinica medica and clinica ematologica in ancona 125
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 123
A policy for the disposal of autologous hematopoietic progenitor cells: report from an Italian consensus panel 123
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 123
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study 123
Anticoagulation and vessel recanalization in cirrhotic patients with splanchnic vein thrombosis: A multidisciplinary “real life” experience 123
Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside. 122
Radioimmunotherapy (Y-90-Zevalin (R)) Combined with BEAM Conditioning Regimen and Autologous Stem Cell Transplantation for the Treatment of Non Hodgkin Lymphomas: Results of An Italian Multicenter Study 122
Allogeneic Stem Cell Transplantation (Allo-SCT) Following a Reduced-Intensity Conditioning (RIC) Regimen in Relapsed Peripheral T-Cell Lymphomas (PTCL): Results at 4 Year of Median Follow-up 122
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression 122
Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma 122
T Repleted Haploidentical Mismatch Allogeneic Versus Autologous Hematopoietic Stem Cell Transplantation In Adult Patients With Acute Leukemia In Complete Remission (CR): A pair-Matched Analysis From The Acute Leukemia Working Party Of EBMT 120
Central pontine myelinolysis after hematopoietic stem cell transplantation: survey in 169 consecutive transplanted patients and review of literature 120
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO) 120
Phototherapy and topical treatments for cutaneous graft vs. host disease in haematopoietic stem cell transplantation patients: a scoping review 120
DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma. 119
In vivo purging with bortezomib and cyclophosphamide, followed by autologous stem cell transplantation and thalidomide consolidation in elderly patients with multiple myeloma 119
Totale 15.111
Salva come PNG Salva come JPEG
Categoria #
all - tutte 195.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 195.269
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.572 0 692 35 184 18 91 172 220 137 236 206 581
2022/20233.672 442 395 366 231 213 498 9 162 1.019 16 240 81
2023/20242.592 453 64 136 431 439 402 70 58 16 66 59 398
2024/20255.800 644 525 173 61 170 165 753 170 1.205 450 541 943
2025/202616.123 1.004 1.174 1.413 2.113 1.246 1.044 2.647 1.530 1.251 1.263 596 842
2026/2027686 637 49 0 0 0 0 0 0 0 0 0 0
Totale 40.443